Lipopolysaccharide-induced Notch signaling activation through JNK-dependent pathway regulates inflammatory response

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Tsao, Po Nien ^a   Wei, Shu Chen ^a   Huang, Miao Tzu ^a   Lee, Ming Cheng ^a   Chou, Hung Chieh ^a   Chen, Chien Yi ^a   Hsieh, Wu Shiun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA SECRETASE INHIBITOR; HIGH MOBILITY GROUP B1 PROTEIN; JAGGED1; LIPOPOLYSACCHARIDE; NOTCH RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN; CALCIUM BINDING PROTEIN; CYTOKINE; DIPEPTIDE; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; N (N (3,5 DIFLUOROPHENACETYL)ALANYL)PHENYLGLYCINE TERT BUTYL ESTER; N-(N-(3,5-DIFLUOROPHENACETYL)ALANYL)PHENYLGLYCINE TERT-BUTYL ESTER; SERRATE PROTEINS; SIGNAL PEPTIDE; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

MURINAE; MUS;

ANIMALS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CYTOKINES; DIPEPTIDES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MAP KINASE KINASE 4; MEMBRANE PROTEINS; MICE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TOLL-LIKE RECEPTORS;

EID: 80051601056     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-56     Document Type: Article

References (30)

1. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR, Crit Care Med 2001 29 1303 1310 10.1097/00003246-200107000-00002 11445675 (Pubitemid 32641789)
2. Current epidemiology of septic shock: the CUB-Rea Network. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B, Am J Respir Crit Care Med 2003 168 165 172 10.1164/rccm.2201087 12851245 (Pubitemid 36920969)
3. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL, Crit Care Med 2007 35 1244 1250 10.1097/01.CCM. 0000261890.41311.E9 17414736 (Pubitemid 46642649)
4. Occurrence and outcomes of sepsis: influence of race. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL, Crit Care Med 2007 35 763 768 10.1097/01.CCM.0000256726.80998.BF 17255870 (Pubitemid 46407788)
5. The epidemiology of sepsis in the United States from 1979 through 2000. Martin GS, Mannino DM, Eaton S, Moss M, N Engl J Med 2003 348 1546 1554 10.1056/NEJMoa022139 12700374 (Pubitemid 36437931)
6. The immunopathogenesis of sepsis. Cohen J, Nature 2002 420 885 891 10.1038/nature01326 12490963 (Pubitemid 36019643)
7. Novel strategies for the treatment of sepsis. Riedemann NC, Guo RF, Ward PA, Nat Med 2003 9 517 524 10.1038/nm0503-517 12724763 (Pubitemid 36597096)
8. Septic shock. Annane D, Bellissant E, Cavaillon JM, Lancet 2005 365 63 78 10.1016/S0140-6736(04)17667-8 15639681 (Pubitemid 40082148)
9. Severe sepsis and therapy with activated protein C. Parrillo JE, N Engl J Med 2005 353 1398 1400 10.1056/NEJMe058160 16192486 (Pubitemid 41362709)
10. Therapeutic intervention and targets for sepsis. Rice TW, Bernard GR, Annu Rev Med 2005 56 225 248 10.1146/annurev.med.56.082103.104356 15660511 (Pubitemid 40299782)
11. Hydrocortisone therapy for patients with septic shock. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, et al. N Engl J Med 2008 358 111 124 10.1056/NEJMoa071366 18184957
12. Notch signalling: a simple pathway becomes complex. Bray SJ, Nat Rev Mol Cell Biol 2006 7 678 689 10.1038/nrm2009 16921404 (Pubitemid 44268213)
13. SnapShot: notch signaling pathway. Ilagan MX, Kopan R, Cell 2007 128 1246 17382890
14. Delta-like 4 induces notch signaling in macrophages: implications for inflammation. Fung E, Tang SM, Canner JP, Morishige K, Arboleda-Velasquez JF, Cardoso AA, Carlesso N, Aster JC, Aikawa M, Circulation 2007 115 2948 2956 10.1161/CIRCULATIONAHA.106.675462 17533181 (Pubitemid 46912098)
15. Delta-like 4 is indispensable in thymic environment specific for T cell development. Hozumi K, Mailhos C, Negishi N, Hirano K, Yahata T, Ando K, Zuklys S, Hollander GA, Shima DT, Habu S, J Exp Med 2008 205 2507 2513 10.1084/jem.20080134 18824583
16. Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. Kijima M, Yamaguchi T, Ishifune C, Maekawa Y, Koyanagi A, Yagita H, Chiba S, Kishihara K, Shimada M, Yasutomo K, Proc Natl Acad Sci USA 2008 105 7010 7015 10.1073/pnas.0709919105 18458347 (Pubitemid 351754521)
17. Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity. Maekawa Y, Minato Y, Ishifune C, Kurihara T, Kitamura A, Kojima H, Yagita H, Sakata-Yanagimoto M, Saito T, Taniuchi I, et al. Nat Immunol 2008 9 1140 1147 10.1038/ni.1649 18724371
18. Notch1 engagement by Delta-like-1 promotes differentiation of B lymphocytes to antibody-secreting cells. Santos MA, Sarmento LM, Rebelo M, Doce AA, Maillard I, Dumortier A, Neves H, Radtke F, Pear WS, Parreira L, Demengeot J, Proc Natl Acad Sci USA 2007 104 15454 15459 10.1073/pnas.0702891104 17878313 (Pubitemid 47502938)
19. Recognition of microorganisms and activation of the immune response. Medzhitov R, Nature 2007 449 819 826 10.1038/nature06246 17943118 (Pubitemid 47598622)
20. Notch-1 up-regulation and signaling following macrophage activation modulates gene expression patterns known to affect antigen-presenting capacity and cytotoxic activity. Monsalve E, Perez MA, Rubio A, Ruiz-Hidalgo MJ, Baladron V, Garcia-Ramirez JJ, Gomez JC, Laborda J, Diaz-Guerra MJ, J Immunol 2006 176 5362 5373 16622004
21. Notch signaling is activated by TLR stimulation and regulates macrophage functions. Palaga T, Buranaruk C, Rengpipat S, Fauq AH, Golde TE, Kaufmann SH, Osborne BA, Eur J Immunol 2008 38 174 183 10.1002/eji.200636999 18085664
22. Autoamplification of Notch signaling in macrophages by TLR-induced and RBP-J-dependent induction of Jagged1. Foldi J, Chung AY, Xu H, Zhu J, Outtz HH, Kitajewski J, Li Y, Hu X, Ivashkiv LB, J Immunol 2010 185 5023 5031 10.4049/jimmunol.1001544 20870935
23. Integrated regulation of Toll-like receptor responses by Notch and interferon-gamma pathways. Hu X, Chung AY, Wu I, Foldi J, Chen J, Ji JD, Tateya T, Kang YJ, Han J, Gessler M, et al. Immunity 2008 29 691 703 10.1016/j.immuni.2008.08.016 18976936
24. The Notch pathway in podocytes plays a role in the development of glomerular disease. Niranjan T, Bielesz B, Gruenwald A, Ponda MP, Kopp JB, Thomas DB, Susztak K, Nat Med 2008 14 290 298 10.1038/nm1731 18311147 (Pubitemid 351347919)
25. Essential role of Notch signaling in effector memory CD8+ T cell-mediated airway hyperresponsiveness and inflammation. Okamoto M, Takeda K, Joetham A, Ohnishi H, Matsuda H, Swasey CH, Swanson BJ, Yasutomo K, Dakhama A, Gelfand EW, J Exp Med 2008 205 1087 1097 10.1084/jem.20072200 18426985 (Pubitemid 351679684)
26. Soluble vascular endothelial growth factor receptor-1 protects mice in sepsis. Tsao PN, Chan FT, Wei SC, Hsieh WS, Chou HC, Su YN, Chen CY, Hsu WM, Hsieh FJ, Hsu SM, Crit Care Med 2007 35 1955 1960 10.1097/01.CCM.0000275273. 56547.B8 17568329 (Pubitemid 47220372)
27. Gamma-secretase activation of notch signaling regulates the balance of proximal and distal fates in progenitor cells of the developing lung. Tsao PN, Chen F, Izvolsky KI, Walker J, Kukuruzinska MA, Lu J, Cardoso WV, J Biol Chem 2008 283 29532 29544 10.1074/jbc.M801565200 18694942
28. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. Yano K, Liaw PC, Mullington JM, Shih SC, Okada H, Bodyak N, Kang PM, Toltl L, Belikoff B, Buras J, et al. J Exp Med 2006 203 1447 1458 10.1084/jem.20060375 16702604 (Pubitemid 43877607)
29. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Kendall RL, Thomas KA, Proc Natl Acad Sci USA 1993 90 10705 10709 10.1073/pnas.90.22.10705 8248162 (Pubitemid 23347111)
30. Presenilin 1 stabilizes the C-terminal fragment of the amyloid precursor protein independently of gamma-secretase activity. Pitsi D, Octave JN, J Biol Chem 2004 279 25333 25338 10.1074/jbc.M312710200 15087467 (Pubitemid 38756788)